Pharma Journalist -

BioDuro and Advent International announced a partnership to support BioDuro's growth as a premier provider of integrated drug discovery, development and manufacturing services. Under…
Read More...

Orgenesis Inc. announced that its subsidiary, Masthercell Global Inc., is expanding into the United States and has executed a lease agreement to build a new 30,000 sq. ft manufacturing…
Read More...

Olon S.p.A. announced the acquisition of Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation, as part of a continuing expansion of its…
Read More...

Concert Pharmaceuticals announced that it has initiated the second Phase 1 clinical trial with CTP-692, a novel deuterium-modified form of D-serine being developed as an adjunctive…
Read More...

SMi Group is proud to announce the 19th Annual Pain Therapeutics Conference is taking place at the Copthorne Tara Hotel in London, UK on the 13th and 14th May 2019. The global…
Read More...

ArQule, Inc.’s partner, Basilea Pharmaceutica announced that it entered into a collaboration with Roche to explore a combination of derazantinib (BAL087) and Roche’s PD-L1-blocking…
Read More...

Following the recent U.S Food and Drug Administration (FDA) approval of the Prior Approval Supplement (PAS) for second-generation Andexxa, Portola Pharmaceuticals, Inc. and Lonza…
Read More...

Ferring Pharmaceuticals (U.S.) announced that it has appointed Sophie Opdyke, Pharm.D., MBA as Vice President, General Manager, Oncology, effective immediately. She most recently served…
Read More...

Ironwood Pharmaceuticals announced the initiation of a Phase 1 study evaluating IW-6463 in healthy volunteers. IW-6463 is an orally administered central nervous system (CNS)-penetrant…
Read More...

Rigel Pharmaceuticals announced that it has entered into an exclusive license and supply agreement with Spain-based Grifols to commercialize fostamatinib disodium hexahydrate in all…
Read More...